Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hällsten

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 15, 2006
Exercise restores skeletal muscle glucose delivery but not insulin-mediated glucose transport and phosphorylation in obese subjectsL Slimani, V Oikonen, K Hällsten, et al.
Journal of Occupational Medicine and Toxicology (London, England)|August 1, 2013
Urinary 2,5-hexanedione excretion in cryptogenic polyneuropathy compared to the general Swedish populationBodil Persson, Magnus Vrethem, Nicola Murgia, et al.
Metabolism: Clinical and Experimental|September 23, 2008
Inverse association between liver fat content and hepatic glucose uptake in patients with type 2 diabetes mellitusRonald Borra, Riika Lautamäki, Riita Parkkola, et al.
Biomed Research International|April 2, 2014
Decreased thioredoxin-1 and increased HSP90 expression in skeletal muscle in subjects with type 2 diabetes or impaired glucose toleranceM Venojärvi, A Korkmaz, S Aunola, et al.
Diabetes|November 28, 2002
Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetesKirsti Hällsten, Kirsi A Virtanen, Fredrik Lönnqvist, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 2004
Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazoneK Hällsten, K A Virtanen, F Lönnqvist, et al.
Diabetes|January 24, 2003
Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjectsKirsi A Virtanen, Kirsti Hällsten, Riitta Parkkola, et al.
The Journal of Clinical Endocrinology and Metabolism|September 29, 2005
Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: a double-blind, randomized study with metforminAntti P M Viljanen, Kirsi A Virtanen, Mikko J Järvisalo, et al.
Obesity Research|February 13, 2003
Insulin- and exercise-stimulated skeletal muscle blood flow and glucose uptake in obese menKirsti Hällsten, Hannele Yki-Järvinen, Pauliina Peltoniemi, et al.
Diabetes|April 28, 2005
Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled studyHåkan K R Karlsson, Kirsti Hällsten, Marie Björnholm, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Endocrinology and Metabolism|June 15, 2006
Exercise restores skeletal muscle glucose delivery but not insulin-mediated glucose transport and phosphorylation in obese subjectsL Slimani, V Oikonen, K Hällsten, et al.
Journal of Occupational Medicine and Toxicology (London, England)|August 1, 2013
Urinary 2,5-hexanedione excretion in cryptogenic polyneuropathy compared to the general Swedish populationBodil Persson, Magnus Vrethem, Nicola Murgia, et al.
Metabolism: Clinical and Experimental|September 23, 2008
Inverse association between liver fat content and hepatic glucose uptake in patients with type 2 diabetes mellitusRonald Borra, Riika Lautamäki, Riita Parkkola, et al.
Biomed Research International|April 2, 2014
Decreased thioredoxin-1 and increased HSP90 expression in skeletal muscle in subjects with type 2 diabetes or impaired glucose toleranceM Venojärvi, A Korkmaz, S Aunola, et al.
Diabetes|November 28, 2002
Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetesKirsti Hällsten, Kirsi A Virtanen, Fredrik Lönnqvist, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 2004
Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazoneK Hällsten, K A Virtanen, F Lönnqvist, et al.
Diabetes|January 24, 2003
Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjectsKirsi A Virtanen, Kirsti Hällsten, Riitta Parkkola, et al.
The Journal of Clinical Endocrinology and Metabolism|September 29, 2005
Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: a double-blind, randomized study with metforminAntti P M Viljanen, Kirsi A Virtanen, Mikko J Järvisalo, et al.
Obesity Research|February 13, 2003
Insulin- and exercise-stimulated skeletal muscle blood flow and glucose uptake in obese menKirsti Hällsten, Hannele Yki-Järvinen, Pauliina Peltoniemi, et al.
Diabetes|April 28, 2005
Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled studyHåkan K R Karlsson, Kirsti Hällsten, Marie Björnholm, et al.
Pageof 4